Skip to content
Review Open access

CDTD-Agent: a retrieval-augmented multi-agent digital health framework for integrated diabetes care: a single-case expert-rated pilot study

Sep 2026 · Frontiers in Digital Health · Vol 8 · 0 citations · 35 references
Medicine

Abstract

Background Diabetes management increasingly requires coordination across Western medicine, traditional Chinese medicine (TCM), and lifestyle-based health management. General-purpose large language models (LLMs) can generate clinical text but may lack reliable source grounding and structured cross-disciplinary reasoning. Methods We developed CDTD-Agent, a retrieval-augmented multi-agent framework that combines a domain-specific knowledge base with an Extract-Retrieve-Reason workflow. The knowledge base included 12 medical textbooks, 8 clinical guidelines, and 183 expert-reviewed diabetes cases. In a blinded single-case pilot evaluation, 30 senior experts rated anonymized recommendations from CDTD-Agent, GPT-4o, DeepSeek-V3.2-Exp, Doubao, and two attending physicians across eight dimensions. Linear mixed-effects models accounted for repeated ratings within evaluators, with Holm correction across eight omnibus tests and global Benjamini-Hochberg correction across 40 focused CDTD-Agent-versus-comparator contrasts. A post hoc backbone-only ablation compared the full framework with Qwen3–235B-A22B using the same case and external prompt without retrieval or role-structured multi-agent processing. Results Significant source effects were detected in all eight dimensions after Holm correction (all adjusted p < 0.001). After global false discovery rate correction, CDTD-Agent received significantly higher ratings than all three general-purpose LLMs in five dimensions: safety, examination appropriateness, Western medicine treatment appropriateness, TCM treatment appropriateness, and evidence adherence. The largest differences occurred in Western medicine treatment appropriateness, where CDTD-Agent scored 4.07 ± 0.94 versus 1.37–1.60 for the general-purpose LLMs (all adjusted p < 0.001). Non-parametric sensitivity analyses agreed with the mixed-effects results for 39 of 40 focused contrasts. In the post hoc ablation, the full framework outperformed the backbone-only condition in seven of eight dimensions after Holm correction; health management was not significantly different (adjusted p = 0.080). Conclusion In this standardized complex T2DM case, CDTD-Agent received favorable expert ratings relative to the evaluated general-purpose LLMs in several clinically important dimensions. These findings are scenario-specific and do not establish generalizable clinical performance or isolate the effects of individual framework components. Multicase, repeated-generation, factorial-ablation, external, and prospective validation is needed before clinical deployment.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.